About Protein ABHD15
Protein ABHD15 (ABHD15) is a protein
from Homo sapiens identified by UniProt accession
Q6UXT9, 468 residues long.
MolForge cross-references it against 0 known binders and
33 disease associations.
Target properties
| Protein name | Protein ABHD15 |
| UniProt accession | Q6UXT9 |
| Gene | ABHD15 |
| Organism | Homo sapiens |
| Length | 468 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (33)
Diseases linked to this target (Open Targets).
- body height · score 0.49
- BMI-adjusted hip circumference · score 0.35
- mean platelet volume · score 0.33
- neurodegenerative disease · score 0.30
- high density lipoprotein cholesterol measurement · score 0.29
- triglyceride measurement · score 0.29
- sitting height measurement · score 0.28
- forced expiratory volume · score 0.27
- hip circumference · score 0.24
- fat body mass · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UXT9-F1 | alphafold | PREDICTED | 79.40 | — |
Amino-acid sequence (468 residues)
MPPWGAALAL ILAVLALLGL LGPRLRGPWG RAVGERTLPG AQDRDDGEEA DGGGPADQFS DGREPLPGGC SLVCKPSALA QCLLRALRRS EALEAGPRSW FSGPHLQTLC HFVLPVAPGP ELAREYLQLA DDGLVALDWV VGPCVRGRRI TSAGGLPAVL LVIPNAWGRL TRNVLGLCLL ALERGYYPVI FHRRGHHGCP LVSPRLQPFG DPSDLKEAVT YIRFRHPAAP LFAVSEGSGS ALLLSYLGEC GSSSYVTGAA CISPVLRCRE WFEAGLPWPY ERGFLLHQKI ALSRYATALE DTVDTSRLFR SRSLREFEEA LFCHTKSFPI SWDTYWDRND PLRDVDEAAV PVLCICSADD PVCGPPDHTL TTELFHSNPY FFLLLSRHGG HCGFLRQEPL PAWSHEVILE SFRALTEFFR TEERIKGLSR HRASFLGGRR RGGALQRREV SSSSNLEEIF NWKRSYTR
Explore Protein ABHD15 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets